fingolimod hydrochloride has been researched along with Cancer of Ovary in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (14.29) | 29.6817 |
| 2010's | 5 (71.43) | 24.3611 |
| 2020's | 1 (14.29) | 2.80 |
| Authors | Studies |
|---|---|
| Kim, ES; Kim, S; Moon, A | 1 |
| Alvarez, RD; Arend, RC; Fehling, SC; Gamblin, TL; Katre, AA; Kreitzburg, KM; Landen, CN; Oliver, PG; van Waardenburg, RCAM; Vance, RB; Yoon, KJ | 1 |
| Booth, L; Dent, P; Poklepovic, A; Roberts, JL; Spiegel, S | 1 |
| Dai, L; Di, W; Qi, Y; Xia, P; Zhang, N | 1 |
| Bae, DS; Cho, YJ; Choi, CH; Choi, JJ; Do, IG; Jeon, HK; Kim, BG; Kim, TJ; Lee, JW; Lee, YY; Ryu, JY; Song, SY; Yoon, G | 1 |
| Di, W; Qi, Y; Wadham, C; Wang, L; Warren, A; Xia, P; Zhang, N | 1 |
7 other study(ies) available for fingolimod hydrochloride and Cancer of Ovary
| Article | Year |
|---|---|
A novel isoxazole compound CM2-II-173 inhibits the invasive phenotype of triple-negative breast cancer cells.
Topics: Apoptosis; Female; Fingolimod Hydrochloride; Humans; Isoxazoles; Male; Ovarian Neoplasms; Triple Negative Breast Neoplasms | 2023 |
FTY720 enhances the anti-tumor activity of carboplatin and tamoxifen in a patient-derived xenograft model of ovarian cancer.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cell Line, Tumor; Cell Proliferation; Cell Survival; Drug Resistance, Neoplasm; Drug Synergism; Female; Fingolimod Hydrochloride; Humans; Mice; Ovarian Neoplasms; Tamoxifen; Xenograft Model Antitumor Assays | 2018 |
Fingolimod augments Pemetrexed killing of non-small cell lung cancer and overcomes resistance to ERBB inhibition.
Topics: Afatinib; Antineoplastic Combined Chemotherapy Protocols; Autophagy; Autophagy-Related Protein 5; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Drug Resistance, Neoplasm; Drug Synergism; ErbB Receptors; Female; Fingolimod Hydrochloride; Gene Knockdown Techniques; Humans; Lung Neoplasms; Ovarian Neoplasms; Pemetrexed; RNA, Small Interfering | 2019 |
Combination of FTY720 with cisplatin exhibits antagonistic effects in ovarian cancer cells: role of autophagy.
Topics: Adenine; Antineoplastic Agents; Autophagy; Cell Count; Cell Death; Cell Line, Tumor; Cisplatin; Drug Antagonism; Drug Resistance, Neoplasm; Female; Fingolimod Hydrochloride; Humans; Immunosuppressive Agents; Ovarian Neoplasms; Propylene Glycols; RNA, Small Interfering; Sphingosine | 2013 |
Sphingosine kinase 1 as a potential therapeutic target in epithelial ovarian cancer.
Topics: Adenocarcinoma, Clear Cell; Animals; Carcinoma, Ovarian Epithelial; Cell Line, Tumor; Cell Proliferation; Female; Fingolimod Hydrochloride; Humans; Immunosuppressive Agents; Mice; Mice, Nude; Neoplasm Transplantation; Neoplasms, Glandular and Epithelial; Ovarian Neoplasms; Phosphotransferases (Alcohol Group Acceptor); Propylene Glycols; Protein Kinase Inhibitors; RNA, Small Interfering; Sphingosine; Xenograft Model Antitumor Assays | 2015 |
News & views in ... Immunotherapy.
Topics: Animals; Antibodies, Blocking; Antineoplastic Agents; Breast Neoplasms; Clinical Trials as Topic; Female; Fingolimod Hydrochloride; HIV Envelope Protein gp120; HIV Infections; Humans; Maximum Tolerated Dose; Multiple Sclerosis; Ovarian Neoplasms; Propylene Glycols; Sphingosine; Thymidylate Synthase; Virus Internalization | 2009 |
FTY720 induces necrotic cell death and autophagy in ovarian cancer cells: a protective role of autophagy.
Topics: Apoptosis; Autophagy; Caspases; Cell Line, Tumor; Cisplatin; Cytoprotection; Drug Screening Assays, Antitumor; Female; Fingolimod Hydrochloride; Humans; Inhibitory Concentration 50; Lysophospholipids; Necrosis; Ovarian Neoplasms; Propylene Glycols; Signal Transduction; Sphingosine | 2010 |